Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sexually Transmitted Diseases

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 79 articles: HTML format

Single Articles

March 2023
1. VAN EER K, Middeldorp M, Dzebisasjvili T, Lamkaraf N, et al
   Effects of two and three vaccinations with the bivalent HPV vaccine on the prevalence and load of HPV in clearing and persistent infections in young women.
   J Infect Dis. 2023 Mar 29:jiad080. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2023
2. BROTHWELL JA, Fortney KR, Batteiger T, Katz BP, et al
   Dispensability of Ascorbic Acid Uptake and Utilization Encoded by ulaABCD for the Virulence of Haemophilus ducreyi in Humans.
   J Infect Dis. 2023;227:317-321.
   PubMed     Abstract available
   
   
   January 2023
3. PHILLIPS S, Cornall AM, Molano M, Jin F, et al
   Performance of human papillomavirus (HPV) attribution algorithms to predict causative genotypes in anal high-grade lesions.
   J Infect Dis. 2023 Jan 2:jiac503. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. SCHWAB NR, Young NE, Nzenwata DU, Toh E, et al
   Characterization of virulence-associated traits in Mycoplasma penetrans strains acting as likely etiological agents of idiopathic non-gonococcal urethritis.
   J Infect Dis. 2023 Jan 2:jiac505. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2022
5. SU X, Le W, Zhu X, Li S, et al
   Neisseria gonorrhoeae infection in women increases with rising numbers of gonococci in partners: Chlamydia coinfection in women increases gonococcal burden.
   J Infect Dis. 2022 Oct 6. pii: 6750085. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2022
6. SHAPIRO SB, Wissing MD, Khosrow-Khavar F, El-Zein M, et al
   Male Circumcision and Genital Human Papillomavirus (HPV) Infection in Males and Their Female Sexual Partners: Findings From the HPV Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study.
   J Infect Dis. 2022;226:1184-1194.
   PubMed     Abstract available
   
   
   
7. AMORRORTU RP, Zhao Y, Fenske NA, Cherpelis BS, et al
   Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections.
   J Infect Dis. 2022;226:1162-1174.
   PubMed     Abstract available
   
   
   
8. ANDRADE PESSOA MORALES J, Marconi C, El-Zein M, Ravel J, et al
   Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection.
   J Infect Dis. 2022;226:1084-1097.
   PubMed     Abstract available
   
   
   
9. MEHTA SD, Nandi D, Agingu W, Green SJ, et al
   Vaginal and Penile Microbiome Associations With Herpes Simplex Virus Type 2 in Women and Their Male Sex Partners.
   J Infect Dis. 2022;226:644-654.
   PubMed     Abstract available
   
   
   July 2022
10. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
    PubMed    
    
    
    June 2022
11. HUNIDZARIRA P, Brown ER, Chirenje ZM, Hillier SL, et al
    Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
    J Infect Dis. 2022 Jun 28. pii: 6619245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. DICKEY BL, Giuliano AR, Sirak B, Abrahamsen M, et al
    Control of Epstein-Barr virus (EBV) in the oral cavity is associated with persistence of oral HPV 16/18 among men from the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2022 Jun 9. pii: 6604966. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
13. MUHR LSA, Eklund C, Lagheden C, Eriksson T, et al
    Head-to-head comparison of bi- and nonavalent human papillomavirus vaccine-induced antibody responses.
    J Infect Dis. 2022 May 10. pii: 6582940. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
14. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
15. BELSHE RB, Blevins TP, Yu Y, Nethington AE, et al
    Neutralizing Antibody Kinetics and Immune Protection Against HSV-1 Genital Disease in Vaccinated Women.
    J Infect Dis. 2022 Feb 24. pii: 6535411. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. JOHNSON RM, Asashima H, Mohanty S, Shaw AC, et al
    Combining cellular immunology with RNAseq to identify novel chlamydia T cell subset signatures.
    J Infect Dis. 2022 Feb 16. pii: 6529704. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
17. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
    Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
    J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
    Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
    J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
19. LEWIS LA, Gulati S, Zelek WM, Morgan BP, et al
    Efficacy of an experimental gonococcal lipooligosaccharide mimitope vaccine requires terminal complement.
    J Infect Dis. 2021 Dec 31. pii: 6491069. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. BRUNHAM RC
    Problems with Understanding Chlamydia trachomatis Immunology.
    J Infect Dis. 2021 Dec 17. pii: 6469012. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. HUI BB, Padeniya TN, Rebuli N, Gray RT, et al
    A gonococcal vaccine has the potential to rapidly reduce the incidence of Neisseria gonorrhoeae infection among urban men who have sex with men.
    J Infect Dis. 2021 Dec 11. pii: 6459455. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. CHRISTENSEN H, Vickerman P
    Gonococcal vaccines for controlling Neisseria gonorrhoeae in men who have sex with men: a promising game-changer.
    J Infect Dis. 2021 Dec 11. pii: 6459454. doi: 10.1093.
    PubMed    
    
    
    October 2021
23. LIU C, Hufnagel K, O'Connell CM, Goonetilleke N, et al
    Reduced Endometrial Ascension and Enhanced Reinfection Associated with IgG Antibodies to Specific Chlamydia trachomatis Proteins in Women at Risk for Chlamydia.
    J Infect Dis. 2021 Oct 5. pii: 6381657. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
24. MARKOWITZ LE, Schiller JT
    Human Papillomavirus Vaccines.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
25. MATTHIAS KA, Connolly KL, Begum AA, Jerse AE, et al
    Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    J Infect Dis. 2021 Sep 8. pii: 6366578. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
26. RAHMAN KS, Kaltenboeck B
    Multipeptide Assays for Sensitive and Differential Detection of Anti-Chlamydia Trachomatis Antibodies.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
27. PAAVONEN J, Turzanski Fortner R, Lehtinen M, Idahl A, et al
    Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
28. DARVILLE T
    Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
29. XU SX, Gray-Owen SD
    Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
30. HORNER PJ, Flanagan H, Horne AW
    Is There a Hidden Burden of Disease as a Result of Epigenetic Epithelial-to-Mesenchymal Transition Following Chlamydia trachomatis Genital Tract Infection?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
31. ZHENG X, Zhong W, O'Connell CM, Liu Y, et al
    Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
32. CONNOLLY KL, Pilligua-Lucas M, Gomez C, Costenoble-Caherty AC, et al
    Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
33. MITCHELL CM, Anyalechi GE, Cohen CR, Haggerty CL, et al
    Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
34. NAGARAJAN UM, Cho C, Gyorke CE, Nagarajan S, et al
    Tumor Necrosis Factor Alpha-Induced Interleukin-1 Alpha Synthesis and Cell Death Is Increased in Mouse Epithelial Cells Infected With Chlamydia muridarum.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
35. HORNER PJ, Anyalechi GE, Geisler WM
    What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
36. RUSSELL MW
    Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
37. HILLIER SL, Bernstein KT, Aral S
    A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease.
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
38. DAVIS GS, Horner PJ, Price MJ, Mitchell HD, et al
    What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?
    J Infect Dis. 2021;224.
    PubMed     Abstract available
    
    
    
39. MAN I, Vanska S, Lehtinen M, Bogaards JA, et al
    Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
    J Infect Dis. 2021;224:481-491.
    PubMed     Abstract available
    
    
    July 2021
40. WINER RL, Lin J, Querec TD, Unger ER, et al
    Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women.
    J Infect Dis. 2021 Jul 28. pii: 6329629. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
41. VAHLE K, Gargano JW, Lewis RM, Querec TD, et al
    Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 20032016.
    J Infect Dis. 2021 Jun 23. pii: 6308446. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
43. RAVINDRAN J, Richardson B, Kinuthia J, Unger JA, et al
    Chlamydia, gonorrhea, and incident HIV infection during pregnancy predict preterm birth despite treatment.
    J Infect Dis. 2021 May 23. pii: 6282455. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. SUNDSTROM K, Dillner J
    How Many Human Papillomavirus Types Do We Need to Screen For?
    J Infect Dis. 2021;223:1510-1511.
    PubMed    
    
    
    
45. HOES J, King AJ, Schurink-van 't Klooster TM, Berkhof PJ, et al
    Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.
    J Infect Dis. 2021 May 8. pii: 6272563. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
46. PAUL P, Hammer A, Rositch AF, Burke AE, et al
    Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior.
    J Infect Dis. 2021;223:1423-1432.
    PubMed     Abstract available
    
    
    
47. CUSTER J, Patel R, Delclos GL, DeSantis SM, et al
    Concurrent and Concordant Oral and Genital High-Risk Human Papillomavirus in the United States: Results from the National Health and Nutrition Examination Survey.
    J Infect Dis. 2021;223:1400-1409.
    PubMed     Abstract available
    
    
    
48. KENYON C
    Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold.
    J Infect Dis. 2021 Apr 2. pii: 6209316. doi: 10.1093.
    PubMed    
    
    
    March 2021
49. LIN HY, Fu Q, Kao YH, Tseng TS, et al
    Antioxidants Associated with Oncogenic HPV Infection in women.
    J Infect Dis. 2021 Mar 18. pii: 6178356. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. WANG K, Dropulic L, Bozekowski J, Pietz HL, et al
    Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.
    J Infect Dis. 2021 Mar 15. pii: 6170962. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
51. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2021
52. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. GAISA MM, Sigel KM, Deshmukh AA, Lenskaya V, et al
    Comparing Anal Cancer Screening Algorithms Using Cytology and HPV DNA Testing in Three High-risk Populations.
    J Infect Dis. 2021 Jan 3. pii: 6060069. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2020
54. SIERRA MS, Tsang SH, Hu S, Porras C, et al
    Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).
    J Infect Dis. 2020 Dec 16. pii: 6039229. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. EL-ZEIN M, Khosrow-Khavar F, Burchell AN, Tellier PP, et al
    Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women.
    J Infect Dis. 2020 Dec 11. pii: 6030992. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
56. POYNTEN IM, Jin F, Garland SM, Hillman RJ, et al
    HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men.
    J Infect Dis. 2020 Nov 21. pii: 5998258. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. YAN Y, Zhang H, Jiang C, Ma X, et al
    Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
    J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. TROJA C, Hoofnagle AN, Szpiro A, Stern JE, et al
    Understanding the role of emerging vitamin D biomarkers on short-term persistence of high-risk HPV infection among mid-adult women.
    J Infect Dis. 2020 Nov 17. pii: 5986719. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. LAAKE I, Feiring B, Jonassen CM, Pettersson JH, et al
    Concurrent infection with multiple human papillomavirus types among unvaccinated and vaccinated 17-year-old Norwegian girls.
    J Infect Dis. 2020 Nov 17. pii: 5986714. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. GAO L, Wang Z, van der Veen S
    Gonococcal adaptation to palmitic acid through farAB expression and FadD activity mutations increases in vivo fitness in a murine genital tract infection model.
    J Infect Dis. 2020 Nov 10. pii: 5973518. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. KAHLER CM
    The Goldilocks Zone: Searching for a Phylogenetic Approach for the Recombinogenic Neisseria gonorrhoeae.
    J Infect Dis. 2020;222:1762-1763.
    PubMed    
    
    
    
62. CEHOVIN A, Jolley KA, Maiden MCJ, Harrison OB, et al
    Association of Neisseria gonorrhoeae Plasmids With Distinct Lineages and The Economic Status of Their Country of Origin.
    J Infect Dis. 2020;222:1826-1836.
    PubMed     Abstract available
    
    
    
63. BETTAMPADI D, Dickey B, Abrahamsen M, Sirak B, et al
    Differences in factors associated with high and low risk oral HPV genotypes in men.
    J Infect Dis. 2020 Nov 5. pii: 5957070. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
64. PICKERING H, Chernet A, Sata E, Zerihun M, et al
    Genomics of Ocular Chlamydia trachomatis after 5 years of SAFE interventions for trachoma in Amhara, Ethiopia.
    J Infect Dis. 2020 Oct 9. pii: 5920008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. KANN H, Lehtinen M, Eriksson T, Surcel HM, et al
    Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity Cohort.
    J Infect Dis. 2020 Oct 3. pii: 5917504. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
66. MEITES E, Winer RL, Newcomb ME, Gorbach PM, et al
    Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018.
    J Infect Dis. 2020 Jun 6. pii: 5854104. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
67. CLIFFORD GM, Combes JD
    Hopes for Prevention of Anal Cancer in Women.
    J Infect Dis. 2020;221:1210-1212.
    PubMed    
    
    
    
68. DE SANJOSE S, Bruni L
    Is it now the time to plan for global gender-neutral vaccination?
    J Infect Dis. 2020 Mar 11. pii: 5803244. doi: 10.1093.
    PubMed    
    
    
    
69. VANSKA S, Luostarinen T, Bausssano I, Apter D, et al
    Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied.
    J Infect Dis. 2020 Mar 11. pii: 5803245. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2020
70. DENG X, Klausner JD
    Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
    J Infect Dis. 2020;221:851-852.
    PubMed    
    
    
    
71. THOMAS JC, Kersh EN, Gernert KM, Shafer WM, et al
    Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    J Infect Dis. 2020;221:852-853.
    PubMed    
    
    
    January 2020
72. JOHNSON RM, Olivares-Strank N, Peng G
    A class II-restricted CD813 T cell clone protects during Chlamydia muridarum genital tract infection.
    J Infect Dis. 2020 Jan 3. pii: 5695851. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
73. KARUNAKARAN KP, Yu H, Jiang X, Chan QWT, et al
    Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
    J Infect Dis. 2019 Oct 10. pii: 5585005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    PubMed    
    
    
    September 2019
75. PATEL P, Bush T, Conley L, Unger ER, et al
    Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
    J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2019
76. WOESTENBERG PJ, King AJ, Van Benthem BHB, Leussink S, et al
    Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.
    J Infect Dis. 2019 Apr 23. pii: 5476422. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. OLESEN SW, Grad YH
    Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae.
    J Infect Dis. 2019 Apr 8. pii: 5430789. doi: 10.1093.
    PubMed    
    
    
    
78. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2019
79. MULLICK C, Murray J
    Correlations between HIV infection and rectal gonorrhea incidence in men who have sex with men: Implications for future HIV pre-exposure prophylaxis trials.
    J Infect Dis. 2019 Jan 31. pii: 5304966. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: